Glatt GmbH

12 patents currently held · Updated Nov 15, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Oct 2028

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Sep 5, 2027
The maintenance fee for Immediate Release Formulations of Cannabinoids (US 11,918,690) comes due Sep 5, 2027. Unpaid by Mar 6, 2028, it lapses early.
1 fee due Oct 16, 2027
The maintenance fee for Taste-masked pharmaceutical compositions containing diclofenac (US 11,957,792) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 8,597,685	Method for production of particles of pharmaceutical substances particles of pharmaceutical substances and the use thereof In force Term ends Oct 16, 2028 · From the USPTO record	In force	Term ends Oct 16, 2028	From the USPTO record
US D721,393	Laboratory fluidized bed equipment In force Term ends Jan 20, 2029 · From the USPTO record	In force	Term ends Jan 20, 2029	From the USPTO record
US 8,187,663	Measurement, monitoring and control of directed product movements in a Wurster-arrangement and suitable systems In force Term ends Jul 15, 2029 · From the USPTO record	In force	Term ends Jul 15, 2029	From the USPTO record
US 11,957,792	Taste-masked pharmaceutical compositions containing diclofenac In force Term ends Apr 19, 2033 · From the USPTO record	In force	Term ends Apr 19, 2033	From the USPTO record
US 9,833,775	Method of manufacturing open-cell bodies and bodies manufactured using said method In force Term ends Mar 25, 2035 · From the USPTO record	In force	Term ends Mar 25, 2035	From the USPTO record
US D921,069	Machine for the development and production of solid pharmaceutical products In force Term ends Jun 1, 2036 · From the USPTO record	In force	Term ends Jun 1, 2036	From the USPTO record
US 11,491,430	Filter unit In force Term ends Jun 2, 2039 · From the USPTO record	In force	Term ends Jun 2, 2039	From the USPTO record
US 12,582,605	Extended Release Formulations of Cannabinoids In force Ends no later than Jul 16, 2039 · Medium confidence	In force	Ends no later than Jul 16, 2039	Medium confidence
US 12,350,371	Immediate release formulations of cannabinoids In force Term ends Sep 23, 2039 · From the USPTO record	In force	Term ends Sep 23, 2039	From the USPTO record
US 11,439,595	Immediate Release Formulations of Cannabinoids In force Term ends Jan 8, 2040 · High confidence	In force	Term ends Jan 8, 2040	High confidence

10 of 12 patents shown.

Pro members see all 12.

Pro members: see all 12 patents

Also on record, not counted in the 12: 3 lapsed for an unpaid fee · 18 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

5 pending · 1 no status recorded

List them